Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-07-15

FDA Approved: LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE — Supplemental Application (Hospira, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Hospira's lidocaine hydrochloride and epinephrine product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lidocaine hydrochloride and epinephrine (Lidocaine hydrochloride and epinephrine)

Snippet

SUPPL AP for LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE (LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE)